Insider filing · BCAX
Lara Meisner
Chief Legal Officer
profile →
Bicara Therapeutics Inc.
BCAX · Healthcare · 40 filings in 24 months
ticker →
Lara Meisner sold $499K of Bicara Therapeutics (BCAX)
Executed Sep 29 2025, disclosed Oct 1 2025, 2 days later.
Value, as filed
$499K
33,807 sh × $14.75
Executed
Sep 29 2025
the trade date, as filed
Disclosed
Oct 1 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
LMLara Meisner (Chief Legal Officer) filed 4 Form 4 reports in the past 24 months (0 purchases, 4 sales), most often in Bicara Therapeutics Inc. (BCAX). The largest single filing was $1.0M of BCAX (79,146 sh across 2 lots, as filed), executed Mar 14 2025.
The name
BCAXHealthcare · Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Lara Meisner in BCAX
BCAXSALE
Bicara Therapeutics Inc.
$182K15,829 sh × $11.49
Exec Sep 15 2025
Filed Sep 17 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $165K
15,829 sh × $10.43
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $1.0M
79,146 sh across 2 lots
Exec Mar 14 2025
Filed Mar 18 2025 · 5:30 PM ET